Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Multiple Sclerosis

  Free Subscription


1 AJNR Am J Neuroradiol
1 BMC Neurol
3 J Neurol Neurosurg Psychiatry
1 Lancet
4 Mult Scler
1 Neurology
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Rev Neurol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJNR Am J Neuroradiol

  1. TSAGKAS C, Horvath-Huck A, Haas T, Amann M, et al
    Fully Automatic Method for Reliable Spinal Cord Compartment Segmentation in Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2023 Jan 26. doi: 10.3174/ajnr.A7756.
    PubMed         Abstract available

    BMC Neurol

    An intervention design for promoting quality of life among patients with multiple sclerosis: a protocol with a planning approach for a mixed methods study.
    BMC Neurol. 2023;23:42.
    PubMed         Abstract available

    J Neurol Neurosurg Psychiatry

  3. TOOROP AA, Hogenboom L, Bloem K, Kocyigit M, et al
    Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2023 Jan 24:jnnp-2022-330793.
    PubMed         Abstract available

  4. AKERSTEDT T, Olsson T, Alfredsson L, Hedstrom AK, et al
    Insufficient sleep during adolescence and risk of multiple sclerosis: results from a Swedish case-control study.
    J Neurol Neurosurg Psychiatry. 2023 Jan 23:jnnp-2022-330123.
    PubMed         Abstract available

  5. SASTRE-GARRIGA J, Rovira A, Garcia-Vidal A, Carbonell-Mirabent P, et al
    Spinal cord reserve in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2023 Jan 23:jnnp-2022-330613.
    PubMed         Abstract available


  6. GUGER M, Ransmayr G, Sonnberger M, Hametner S, et al
    Tumefactive multiple sclerosis presents with painless progressive hemiparesis and aphasia.
    Lancet. 2023;401:226.

    Mult Scler

  7. CHIA NH, Redenbaugh V, Chen JJ, Pittock SJ, et al
    Corpus callosum involvement in MOG antibody-associated disease in comparison to AQP4-IgG-seropositive neuromyelitis optica spectrum disorder and multiple sclerosis.
    Mult Scler. 2023 Jan 24:13524585221150743. doi: 10.1177/13524585221150743.
    PubMed         Abstract available

  8. HU C, Dewey BE, Mowry EM, Fitzgerald KC, et al
    Deep gray matter substructure volumes and depressive symptoms in a large multiple sclerosis cohort.
    Mult Scler. 2023 Jan 24:13524585221148144. doi: 10.1177/13524585221148144.
    PubMed         Abstract available

  9. SADOVNICK D, Criscuoli M, Yee I, Carruthers R, et al
    The Canadian Multiple Sclerosis Pregnancy Study: First-trimester miscarriages in women with multiple sclerosis.
    Mult Scler. 2023 Jan 22:13524585221146270. doi: 10.1177/13524585221146270.
    PubMed         Abstract available

  10. ABBADESSA G, Miele G, Maida E, Vanore E, et al
    Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis.
    Mult Scler. 2023 Jan 22:13524585221147635. doi: 10.1177/13524585221147635.
    PubMed         Abstract available


  11. CACCIAGUERRA L, Morris P, Tobin WO, Chen JJ, et al
    Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
    Neurology. 2023 Jan 23:10.1212/WNL.0000000000206820.
    PubMed         Abstract available

    PLoS One

  12. PRUMMER JK, Stein VM, Marti E, Lutterotti A, et al
    Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin.
    PLoS One. 2023;18:e0280864.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  13. SHINODA K, Li R, Rezk A, Mexhitaj I, et al
    Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.
    Proc Natl Acad Sci U S A. 2023;120:e2207291120.
    PubMed         Abstract available

    Rev Neurol

  14. DE SA J, Ferreira J, Macedo AM
    [Actual adherence to dimethyl fumarate in patients with relapsing-remitting multiple sclerosis].
    Rev Neurol. 2023;76.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.